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A new recombinant adenovirus was constructed that expressed the nucleocapsid (C protein or p14) of the bovine viral
diarrhea virus (BVDV) under the control of a tetracycline-regulatable promoter. Mice covaccinated with this recombinant
adenovirus, accompanied by another recombinant adenovirus expressing the trans-activator protein, induced a strong
humoral immune response to the BVDV/C protein as detected by ELISA. Splenocytes from mice immunized with the
recombinant adenovirus showed a specific proliferation response to both genotypes (type 1 and 2) of BVDV. High levels of
IFN-g were detected in the supernatant of murine mononuclear cells of mice immunized by the recombinant adenovirus when
stimulated in vitro by both genotypes of BVDV. These results indicate that this recombinant adenovirus is highly immunogenic
and stimulates both cellular and humoral immune responses against the nucleocapsid of BVDV. © 1999 Academic Press
Key Words: bovine viral diarrhea virus; nucleocapsid; recombinant adenoviruses; tetracycline-regulatable promoter;
humoral immune response; cellular immune response.
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fIntroduction. Bovine viral diarrhea virus (BVDV) be-
ongs to the pestivirus genus. This genus, with the genus
lavivirus and the hepatitis C virus group, forms the family
laviviridae. The virions of pestiviruses consist of a pos-
tive-stranded RNA and four structural proteins. These
re the nucleocapsid C protein (p14) and the three en-
elope glycoproteins Erns (gp48), E1 (gp25), and E2
gp53) (29). Recently, BVDV strains have been divided
nto two genotypes (type 1 and 2) (10, 23). The C protein
p14) of BVDV is highly conserved among many different
estiviruses yet in contrast to hepatitis C capsid protein,
VDV/C protein does not appear to be immunogenic
ince sera from convalescent cattle do not contain anti-
odies to C protein (1, 11, 12). In this report we expressed
fragment of the BVDV genome containing the coding
egion of the BVDV/C protein in a recombinant adenovi-
us (rAdTR5-DC/C-GFP) under the control of the tetracy-
line-regulatable promoter. In this system, the expres-
ion of a target gene, placed under the control of the
romoter containing the tetracycline operator sequence
tet O), can be induced by the tetracycline-regulated
rans-activator (tTA) protein. The tTA protein can be sup-
lied by using the 293-tTA cell line (a stable 293 cell line
1 To whom correspondence and reprint requests should be ad-
oressed. Fax: (450) 778-8105. E-mail: elazhary@medvet.umontreal.ca.
1hat constitutively expresses the tTA protein) or by coin-
ection with a recombinant virus such as Ad5CMV-tTA
17). The transcription of the tTA protein can be prevented
y adding tetracycline at a concentration that is not toxic
or eukaryotic cells (8). Previously, we have demon-
trated that murine mononuclear cells of mice immu-
ized by a recombinant fowlpox virus (2) or by two ad-
noviruses (unpublished results) expressing the enve-
ope E2 protein of BVDV can produce a Th1 response
nly after homologous stimulation with BVDV type 1. An
fficient vaccine has to protect the animal against all
ypes of viruses and determination of immune responses
o the more conserved proteins of BVDV, such as the
ucleocapsid, is a subject of interest.
In this study we demonstrated that the BVDV/C protein
nduced both humoral and cellular immune responses in
mouse model. This report also shows that a recombi-
ant adenovirus with a tetracycline-regulatable promoter
an express a foreign gene in vivo when it is induced by
nother adenovirus that supplies the tTA protein.
Results and Discussion. Construction of rAdTR5-DC/
-GFP. At the start of this study the positions of the
ucleocapsid protein C and the glycoprotein Erns had
een determined only for C and Erns of classical swine
ever virus (CSFV) by amino acid sequencing (24, 27). In
ur cloning strategy, we included the conserved se-
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2 RAPID COMMUNICATIONuence situated upstream and downstream of the C
rotein. These sequence are conserved between several
estiviruses. A fragment of the BVDV/NADL genome con-
aining the presumed BVDV/C protein was amplified by
CR and subsequently cloned into pGEM-T to be finally
ransferred into the shuttle plasmid (pAdTR5-DC/GFP).
y comparing the NADL sequence with other pestivi-
uses (19), our construct was found to contain 21 amino
cids of Npro at the N-terminal and 12 amino acids of
rns at the C-terminal.
Homologous recombination between transfer vector
pAdTR5-DC/GFP) (18) and Ad5/DE1DE3 (7) resulted in
AdTR5-DC/C-GFP in which the expression of the
VDV/C gene was under the control of the tetracycline-
egulatable promoter (TR5). This recombinant adenovi-
us also coexpressed the GFP protein so that the recom-
inant plaques could be rapidly identified by fluores-
ence microscopy. The expression of GFP by the TR5
romoter in 293A cells was sufficient to identify green
laques in the uninduced state. The rAdTR5-DC/C-GFP
as defined by performing PCR and visualizing the co-
xpression of the GFP gene (data not shown). One of the
ositive plaques was subjected to three consecutive
ounds of plaque purification and the expression of the
VDV/C protein was detected by radioimmunoprecipita-
ion using a monospecific antiserum as described below.
We used a dicistronic inducible system for the follow-
ng reasons: First, coexpression of GFP simplified the
loning selection since GFP fluorescence can be easily
isualized in live cells with a standard fluorescence mi-
roscope. Second, this system allowed the expression of
he transgene in the presence of tTA protein and could
e completely inactivated at tetracycline concentrations
hat are not toxic for eukaryotic cells (8). These two
haracteristics allow the generation of recombinant ad-
noviruses in which the production of the transgene may
e toxic and they permit the control of the transgene
xpression in vitro (17) and in vivo (26). Previously, we
emonstrated that recombinant adenovirus (with a con-
titutive promoter) expressing the NS3 of BVDV (a viral
rotease) has a titer about 10 times lower than that of
arental adenovirus, probably due to the effect of the
ecombinant protein (3). Finally, previous observations in
ur laboratory have demonstrated that this system can
xpress the E2 protein of BVDV in vivo and in vitro as
fficiently as the constitutive promoter (unpublished re-
ults). Thus the use of an inducible promoter appears to
e the best choice for an uncharacterized protein (such
s BVDV/C protein).
In Vitro Expression of BVDV/C Protein. SDS–PAGE
nalysis of the MBP–BVDV/C fusion protein (the result of
usion between maltose-binding protein and BVDV/C
rotein as described under Materials and Methods)
howed a protein band of approximately 60 kDa. The
altose-binding protein was responsible for 42.7 kDa of hhis, and 17 kDa (predicted molecular mass for our con-
truct) was the BVDV/C expressed protein (data not
hown). Figure 1 shows that the “anti-C antibody” precip-
tated a 17-kDa protein from 293-tTA cells infected by
AdTR5-DC/C-GFP (Fig. 1a, lane 3). In 293A cells, expres-
ion of the recombinant protein was possible after coin-
ection of rAdTR5-DC/C-GFP with Ad5CMV-tTA (Fig. 1b,
ane 3). However, the level of expression in 293A cells
as lower than in 293-tTA cells. These observations
ere not surprising because in 293A cells, the expres-
ion of the BVDV/C protein depends on coinfection of
oth viruses in the same cell. We also detected a band of
bout 23 kDa only in 293-tTA cells infected by rAdTR5-
C/C-GFP (Fig. 1a, lane 3). This band could be a post-
ranslation modification of the recombinant protein.
hese data simply could be a consequence of the differ-
nt levels of expression in the two cell lines. As is
emonstrated in Fig. 1b, the level of expression of the
7-kDa band is clearly lower than the same band in Fig.
a. This reduction in expression of the 23-kDa band
ould make it undetectable in Fig. 1b. As a second
FIG. 1. In vivo expression of rAdTR5-DC/C-GFP in 293-tTA (a) and
93A (b) cells. The 293-tTA cells were infected with Ad5/DE1DE3 (a,
ane 2) or rAdTR5-DC/C-GFP (a, lane 3). The 293A cells were infected
ith Ad5/DE1DE3 1 Ad5CMV-tTA (b, lane 2) or rAdTR5-DC/C-GFP 1
d5CMV-tTA (b, lane 3). The MDBK cells were mock-infected (a and b,
ane 1) or were infected by BVDV/NADL (a and b, lane 4). After meta-
olic labeling, the cell lysates were precipitated with the anti-C anti-
ody as described under Materials and Methods. The molecular
eight markers are shown on the left side.ypothesis to explain this result, it has already been
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3RAPID COMMUNICATIONemonstrated that the tTA protein could influence tran-
criptional factors in some cells (15). Thus the difference
n the level of tTA protein expression between the two
ines could have some effect on the posttranslation mod-
fication of the BVDV/C protein. The anti-C antibody did
ot precipitate any proteins with similar molecular
asses (17 and 23 kDa) in 293-tTA cells infected by
d5/DE1DE3 (Fig. 1a, lane 2) and 293A cells coinfected
y rAdTR5-DC/C-GFP and Ad5CMV-tTA (Fig. 1b, lane 2).
n the MDBK cells infected with BVDV the BVDV/C pro-
ein was precipitated with anti-C antibody as a 14-kDa
rotein at the lower limits of detection (Figs. 1a and 1b,
ane 4). This may be because the anti-C antibody had a
ow titer and was used at high concentrations (10–15% of
ell lysate) in order to detect the expression of the
VDV/C protein. There was no band of a similar size in
ock-infected MDBK cells (Figs. 1a and 1b, lane 1).
Demonstration of the Specificity of Anti-C Antibody.
he anti-C antibody reacted with the fusion protein
MBP–BVDV/C protein) in our ELISA assay and also in
ur ELISA assay in which the plates were coated with
onpurified BVDV (2). In addition, none of the adenovirus
roteins or 293A, 293-tTA, and MDBK cells (up to 55 kDa)
ere precipitated by this antibody (Figs. 1a and 1b). The
nly BVDV protein that was precipitated by this antibody
as BVDV/C (Figs. 1a and 1b, lane 4) in MDBK cells
nfected with the virus. The N-terminal and C-terminal
xtremities of the recombinant proteins did not produce
ny antibody against Npro or Erns. We did not find any
eutralizing antibodies against the Erns protein in rabbit
FIG. 2. Humoral immune response to recombinant adenovrirus expr
iluted 1:20 to 1:21480, were tested in an ELISA assay as described und
hree times those of mice in group I for each dilution were considered a
ilution is shown above each average point. Group I, mice immunized
-GFP 1 Ad5CMV-tTA. Results are the means 6 standard deviation. Thr mouse sera after vaccination with recombinant protein snd rAd/C, respectively (data not shown). These data
onfirm that the BVDV/C protein in our construct is the
nly important protein for induction of humoral immunity
gainst the BVDV.
Humoral Immune Response Against BVDV/C Protein.
wo groups of six mice were immunized by Ad5/
E1DE3 1 Ad5CMV-tTA (referred to as parental adeno-
irus or group I) or rAdTR5-DC/C-GFP 1 Ad5CMV-tTA
referred to as rAd/C or group II). At 7 weeks postinfec-
ion (p.i.) mouse sera were tested by ELISA for BVDV-
pecific antibody. The averages of the optical density
O.D.) for both groups, starting at a dilution of 1:20 up to
:20,480, are shown in Fig. 2. The difference between the
wo groups was extremely significant (Student t tests,
5 0.0005). The cut-off level (the O.D. that represents a
ositive result) for each dilution was established at three
ime the O.D. average of mice in group I. The end-point
ilutions for mice in group II were between 1:320 and
:10,240. The number of mice with positive titers for each
ilution is also shown in Fig. 2. All mice in group II were
ositive at 1:320. However, the end-point dilutions for two
mmunized rabbits at 13 weeks p.i. were only 1:40 and
:80. None of the antibodies against BVDV/C protein
roduced in mice or rabbits neutralized the BVDV/NADL
train in vitro (data not shown).
However, other authors (1) have not found any anti-
odies to BVDV/C protein after natural or experimental
nfection in cattle. Yet in our study, we were successful in
nducing a significant BVDV/C antibody response in
ouse sera after immunization with rAd/C. Previous
the nucleocapsid of BVDV. At 7 weeks postinfection the mouse sera,
erials and Methods. The mouse sera with optical densities higher than
ive. The number of positive sera over the total number of sera for each
5/DE1DE3 1 Ad5CMV-tTA. Group II, mice immunized by rAdTR5-DC/
rence between the two groups was extremely significant (P 5 0.0005).essing
er Mat
s posit
by Adtudies indicated that the first generation of recombinant
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4 RAPID COMMUNICATIONdenoviruses (E1-deleted) elicited destructive class I-re-
tricted cytotoxic T lymphocytes to both viral and trans-
ene proteins (such as LacZ ). These recombinant ad-
noviruses also induced an inflammatory reaction at the
ite of injection (30, 31). This phenomenon was not de-
ected when a recombinant adeno-associated virus was
sed alone for expression of the lacZ gene (5). This
adjuvant effect” of adenovirus protein to stimulate an
mmune response to transgene products could explain
ur success in the production of humoral and cellular
mmune responses against the BVDV/C protein. The lack
f a strong humoral immune response in rabbits follow-
ng immunization with the MBP-BVDV/C protein lends
eight to this hypothesis. The mouse sera were also
ositive by ELISA when native nonpurified BVDV (NADL
train) was used to coat the plate (2) although the aver-
ge end-point dilutions decreased about fourfold (data
ot shown). The proteins expressed by adenovirus prob-
bly did not have exactly the same configurations as the
ative protein and consequently the mouse sera reacted
etter with the recombinant protein than the native form.
Previously, we carried out in vitro studies with a re-
ombinant adenovirus expressing the GFP protein under
he control of tetracycline-regulatable promoter. We
ound that the best level of expression of GFP protein in
onpermissive cells (e.g., HeLa cells) for defective ade-
ovirus was obtained after coinfection with a 3:1 ratio of
AdCMV-tTA to the recombinant adenovirus that ex-
ressed the GFP and that had been infected at a very
igh m.o.i. (total of 1500, data not shown). In the present
ork, for in vivo studies we chose the same ratio with a
ose of 5 3 108 PFU for rAdTR5-DC/C-GFP and 1.5 3 109
FU for Ad5CMV-tTA. The dose of 108 to 109 is used
urrently for vaccination of laboratory animals by recom-
inant adenovirus. In the experiments where difference
oses were administrated, the immune response ap-
eared to be dose-dependent (4, 20). However, dose-
ependency was not determined in the present study.
Cellular Immunity. T-cell responses were measured as
ntigen-dependent cell proliferation and production of
ytokines following in vitro stimulation with BVDV strains.
n the presence of indomethacin, an inhibitor of prosta-
landin E2 (25), the murine mononuclear cells (MNC) of
ice immunized by rAd/C (group II) showed a clear class
I restricted stimulation with both types of BVDV strains
NADL type 1 and 125 type 2) (Fig. 3). The cross-geno-
ypic proliferative response in MNC of mice immunized
y rAd/C that expressed the BVDV/C protein of the NADL
train (type 1) to the BVDV/125 strain (type 2) could be a
onsequence of the homology of this protein between
hese two genotypes and this suggests a substantial
ross-reactivity at the T-cell level. The proliferation re-
ponse to both strains was completely abolished in the
bsence of indomethacin (data not shown). These re-ults are not surprising since it is known that prostaglan-
ins inhibit T-cell mitogenesis (21).
The production of IL-2, IL-4, and IFN-g was also mon-
tored in the supernatants of murine MNC immunized
ith the rAd/C or parental adenovirus. IL-12 and cyto-
ines that modulate the effectiveness of IL-12, such as
FN-g and IFN-a, are key regulators of Th1 differentiation,
hile IL-4 is a key regulator of Th2 differentiation (22).
he murine MNC, immunized with the rAd/C (group II),
roduced 4249 6 164 (mean 6 standard deviation) pg/ml
f IFN-g following stimulation by the BVDV/NADL strain
nd 2249 6 153 pg/ml of IFN-g by the BVDV/125 strain
Fig. 4). This remarkable production of IFN-g in mice
mmunized with rAd/C could be an indicator of the acti-
ation of specific Th1 cells. IFN-g was detected at much
ower levels (593 6 3 pg/ml) in supernatants of murine
NC from mice immunized with parental adenovirus and
timulated with BVDV/NADL. Between the two groups of
ice, there was no detectable difference in the produc-
ion of IL-2 or IL-4 from murine MNC stimulated with both
VDV strains (data not shown). The lymphoproliferation
esponses and production of IFN-g are indicators of Th1
ctivation and explain the absence of IL-4 production by
h2 (21). The lack of IL-2 could be caused by the IFN-g
ince it is a powerful inducer of inducible nitric oxide
ynthesis, which can inhibit production of IL-2 by Th1
ells (14).
FIG. 3. Proliferation responses of murine mononuclear cells stimu-
ated with BVDV/NADL or BVDV/125 strains. The murine mononuclear
ells of mice in group I (Ad5/DE1DE3 1 Ad5CMV-tTA, open bar) and
roup II (rAdTR5-DC/C-GFP 1 Ad5CMV-tTA, black bar) stimulated in
itro with BVDV/NADL strain (bars 1 and 2) or BVDV/125 strain (bars 3
nd 4). The stimulation index for each group was calculated by the
ollowing formula: SI 5 average counts per minute in antigen stimu-
ated wells/average counts per minute in wells containing only cells
ith medium. Only the results of stimulation with optimal dilution for
ach BVDV strain are presented in this figure. Results are the means 6
tandard deviation and are representative of three experiments. The
ifference between the two groups was significant (P , 0.05).Our construct also contained the non-C protein se-
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5RAPID COMMUNICATIONuences. The role of these two short sequences in hu-
oral immunity should be negligible as discussed pre-
iously. However, we were not able to positively exclude
hese two peptides from cellular immune responses.
owever, the present published data about the Npro, C,
nd Erns proteins of other Flaviviridae, particularly HCV
nd CSFV, suggest that BVDV/C is the active protein in
ur constructs (11, 12, 28).
This study showed that a recombinant adenovirus with
tetracycline-regulatable promoter can express an im-
unogenic foreign gene in vivo when it is induced by
nother adenovirus that supplies the tTA protein. In pre-
ious studies we have shown that this inducible pro-
oter can drive the expression of the BVDV E2 protein as
fficiently as a constitutive promoter (unpublished re-
ults). Despite this, we did not find any significant toxicity
r differences between the virus titers of recombinant
denovirus and parental virus. Our results confirm that
uch a tetracycline-regulatable promoter can be used for
xpression of an uncharacterized gene.
This article also reports the induction of both humoral
nd cellular immune responses to the nucleocapsid of
VDV in a mouse model. The experiments to examine
he immune responses to such recombinant proteins
ere carried out in mice because the immune mecha-
isms are well known, significant numbers of animals
an be used, and inbred lines are available. Despite the
ifferences in immune responses between mice and
attle, the normal host for the virus, almost all the data on
FIG. 4. Detection of IFN-g in the supernatant of vaccinated murine
ononuclear cells after stimulation by BVDV strains. The murine mono-
uclear cells of mice immunized with Ad5/DE1DE3 1 Ad5CMV-tTA
group I, open bar) or rAdTR5-DC/C-GFP 1 Ad5CMV-tTA (group II, black
ar) were stimulated by BVDV/NADL (bars 1 and 2) or BVDV/125 strains
bars 3 and 4). The concentrations of IFN-g were determined in the
upernatant of the stimulated cells by ELISA and are expressed as
g/ml. Results are the means 6 standard deviation and are represen-
ative of two experiments. u/d, undetectable. The difference between
he two groups was significant (P , 0.05).and B cell epitopes have been obtained using mono- tlonal constructs that were the result of the murine
mmune response to BVDV proteins. These have proved
o mimic very well the bovine response. The ability of
Ad/C to stimulate the immune response to the more
onserved core proteins has important implications in
he development of vaccines against BVDV.
Materials and Methods. Cultures and viruses. Madin–
arby bovine kidney (MDBK) cells (free of BVDV) were
btained from the American Type Culture Collection
Rockville, MD) and grown in Dulbecco’s modified Ea-
le’s medium (Gibco), supplemented with 5% fetal bovine
erum (FBS) [free of antigen and antibody against BVDV,
Gibco)]. The NADL strain of BVDV (type 1) and 125 strain
BVDV type 2) were obtained from ATCC and USDA
Ames, IA), respectively, and were propagated in MDBK
ells in the presence of 2% FBS. The conditions for
ulture of human 293 cells, either the original anchorage-
ependent 293A line (9) or 293S (obtained from Cold
pring Harbor Laboratories), an anchorage-independent
lone, were as described previously (6, 16). Human ad-
novirus type 5 with deletions in the E1 and E3 regions
d5/DE1DE3 (7) and Ad5CMV-tTA (17) was amplified in
93S cells.
Construction of the Transfer Vector. Nucleotides 827 to
232 of the BVDV/NADL strain were amplified after RNA
xtraction and cDNA synthesis by using forward primer
9-GAGATCTACCATGTACCAAAGGGTGTTCAGGTGG-39
nd reverse primer 59-TAGATCTCTACCCATTATCTTG-
AGGTTCCA-39. To facilitate the cloning of the PCR prod-
ct, a BglII restriction site was added to both primers.
he forward primer also contains an in-frame transla-
ional start codon and the reverse primer contains an
n-frame translational stop codon for termination of ex-
ression at the 39 end. The PCR product was cloned into
he pGEM-T vector (Promega) and the coding region for
he BVDV/C protein was then excised from pGEM-T/C by
glII digestion and cloned in the BglII site of the pAdTR5-
C/GFP plasmid (18) to generate pAdTR5-DC/C-GFP.
Construction of Recombinant Adenovirus. The transfer
ector, pAdTR5-DC/C-GFP, was linearized at the unique
esI site and cotransfected with ClaI-digested Ad5/
E1DE3 (7) into 293A cells as described previously by
assie et al. (17). The recombinant adenovirus that ex-
ressed the BVDV/C protein was designated rAdTR5-
C/C-GFP.
Generation of the Fusion Protein and Monospecific
ntisera. The recombinant BVDV/C protein was also ex-
ressed in a bacterial system after the coding sequence
ad been cloned at the BamHI site of pMAL-c2 plasmid
New England Biolabs). The fusion protein (maltose bind-
ng protein and BVDV/C protein, referred to as MBP-
VDV/C protein) was purified using the maltose-binding
rotein’s affinity for maltose according to the manufac-urer’s instructions (New England Biolabs). A monospe-
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6 RAPID COMMUNICATIONific antiserum against the BVDV/C protein, anti-C anti-
ody, was generated in two female rabbits (New Zea-
and) by intramuscular injection of 100 mg of purified
BP-BVDV/C fusion protein accompanied by complete
reund’s adjuvant for the first immunization and incom-
lete Freund’s adjuvant for subsequent immunizations at
, 6, and 10 weeks after the first immunization.
Radioimmunoprecipitaton. Approximately 2 3 106 293-
TA cells in a 60-mm dish were infected at m.o.i. of 20
FU/cell with rAdTR5-DC/C-GFP or Ad5/DE1DE3. The
xpression of recombinant protein was also investigated
n 293A cells by coinfection of two viruses: rAdTR5-DC/
-GFP or Ad5/DE1DE3 with Ad5CMV-tTA (m.o.i. of 20 for
ach virus). At 16 h postinfection, after 1 h of starvation in
MEM lacking methionine and cysteine, cells were la-
eled in the same medium for 2 h in the presence of
35S]methionine/[35S]cysteine (Amersham; 100 Ci per
ish). Metabolic labeling of MDBK cells infected by the
VDV/NADL strain was as described previously (2). The
roteins were precipitated by using anti-C antibody and
rotein A–Sepharose before being analyzed by SDS–
AGE (13).
Immunization Protocol. Two groups of six BALB/c mice
ere immunized with 5 3 108 PFU of Ad5/DE1DE3 1
.5 3 109 PFU of Ad5CMV-tTA (group I) or 5 3 108 PFU of
AdTR5-DC/C-GFP 1 1.5 3 109 PFU of Ad5CMV-tTA
group II) by subcutaneous (sc.) injection. The booster
mmunization was performed at 4 weeks p.i. with same
ose. The blood samples were collected at 0, 4, and 7
eeks p.i. by orbital plexus puncture.
Enzyme-Linked Immunosorbant Assay (ELISA). We de-
eloped an ELISA detection system by using the purified
BP-BVDV/C protein at 250 pg/well for coating the
lates. After blocking with 5% skim milk in Tris-buffered
aline (12.5 mM trizma hydrochloride, 46.4 mM NaCl,
.005% thimerosal, and 0.05% Tween 20, pH 7.0), for 1 h
t 37°C, twofold serum dilutions starting at 1:20 to
:20,480 were added to the wells in duplicate, and the
lates were incubated for 30 min at 37°C. HRP goat
nti-mouse IgG (1:8000, Bio-Rad) was used as the sec-
nd antibody (30 min at 37°C) and tetra-methylbenzidine
as used as the substrate. Color was allowed to develop
or 10 min at room temperature at which time absor-
ance was determined at 450 nm.
Proliferation Response of Murine Mononuclear Cells.
t 7 weeks p.i. splenocytes of mice from groups I (im-
unized with parental adenoviruses) and II (immunized
ith rAd/C) were stimulated in vitro by nonpurified BVDV
trains of NADL or 125 as described previously (2) with
ne modification. The stimulated murine MNC were kept
n the presence or in the absence of 30 mM indometha-
in, an inhibitor of prostaglandin E2 (25). The stimulation
ndex (SI) was calculated as follows: SI 5 average
ounts per minute in antigen stimulated wells/averageounts per minute in wells containing only cells with
edium.
For the cytokine production assay, 1.5 3 106 murine
NC were stimulated with BVDV (NADL and 125 strains)
2) in the presence of 30 mM indomethacin. Three days
ater, 100 ml of supernatant was used in duplicate in a
ytokine ELISA assay (PharMingen) for detection of IL-2
nd IL-4 (Th1-type cytokines) and IFN-g (a Th2-type cy-
okine) according to the manufacturer’s instructions.
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